Abstract
Recently, nano-scaled chirality has attained significant attraction from various research areas depending on its fundamental significance in the matter of living and nature. In this work, we designed and fabricated d-/l-Pe-Au nanoparticles (Chiral Penicillamine-modified Gold NPs), system for the treatment of Alzheimer’s disease. RTCA (real-time cell analysis) assay was performed using rat PC12 (Pheochromocytoma) cells to investigate the capable cytotoxicity of d-/l-Pe-Au nanoparticles. At any point of given time, with increase in the concentration of d-Pe-Au nanoparticles, we observed a significant decrease in the cell index, which suggests that the cytotoxic effect on the PC12 cells depends on the concentration. We believe that the results obtained may be significant for other chiral nanoparticles in the treatment of the disease called Alzheimer’s and also has an extensive utilization in the studies and applications based on NPs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
